Vaccination for Splenectomy Patients
All patients undergoing splenectomy require four essential vaccines: pneumococcal (PCV followed by PPSV23), meningococcal (both MenACWY and MenB), Haemophilus influenzae type b (Hib), and annual influenza vaccination, administered at least 2 weeks before elective surgery or at least 2 weeks after emergency splenectomy. 1, 2
Core Vaccination Protocol
Pneumococcal Vaccination
- Administer PCV13 (or newer PCV15/PCV20) first, followed by PPSV23 at least 8 weeks later for vaccine-naïve patients aged ≥2 years 1, 2
- For patients previously vaccinated with PCV13 only, give PCV20 at least 1 year later 2, 3
- A second dose of PPSV23 should be administered 5 years after the first dose, then revaccinate every 5-10 years for lifelong protection 1, 2
- This prime-boost strategy with PCV followed by PPSV23 produces higher antibody levels than PPSV23 alone 1
Meningococcal Vaccination
- Administer both MenACWY and MenB vaccines due to 40-70% mortality rates from meningococcal infections in asplenic patients 1, 2, 4
- Give MenACWY as a 2-dose primary series, 8 weeks apart, for patients aged ≥10 years 2, 3
- Revaccinate with MenACWY every 5 years for life 1, 2
- Administer MenB as either a 2-dose or 3-dose series depending on formulation 2, 3
- Revaccinate with MenB every 2-3 years if risk remains 2, 3
Haemophilus Influenzae Type b (Hib)
- One dose of Hib vaccine is required for all unvaccinated asplenic persons aged ≥5 years 1, 2, 4
- No revaccination is needed if the patient completed the childhood Hib series 3
Influenza Vaccination
- Annual inactivated or recombinant influenza vaccine for life for all asplenic patients aged ≥6 months 2, 3, 4
- Never use live attenuated influenza vaccine (nasal spray) in asplenic patients 4
Critical Timing Considerations
Elective Splenectomy
- Administer all vaccines at least 2 weeks before elective surgery (ideally 4-6 weeks if scheduling permits) to ensure optimal antibody response 1, 2
- The 2-week pre-surgery timing is essential because antibody formation generally takes 9 days, and this timing results in higher antibody concentrations compared to vaccination at shorter intervals 1, 3
Emergency Splenectomy
- Wait at least 14 days post-operatively before vaccinating once the patient is stable after emergency/trauma splenectomy 1, 2
- Antibody response is suboptimal if vaccines are given before this 14-day window 1, 3
Additional Preventive Measures
Antibiotic Prophylaxis
- Offer lifelong prophylactic antibiotics (typically phenoxymethylpenicillin) to all patients, with highest priority in the first 2 years post-splenectomy 1, 2, 3
- Use erythromycin for penicillin-allergic patients 1
- Provide emergency standby antibiotics (amoxicillin) for home use at the first sign of fever, malaise, or chills 1, 2, 3
Patient Education and Documentation
- Issue medical alert identification indicating asplenic status 2, 3
- Formally notify primary care providers of the patient's asplenic status to ensure appropriate ongoing care 2, 3
- Educate patients about their lifelong increased infection risk and the need for immediate medical attention with fever >101°F (38°C) 2, 3, 4
- Provide written information about overwhelming post-splenectomy infection (OPSI) risk 3
Understanding the Clinical Stakes
- OPSI presents as fulminant sepsis, meningitis, or pneumonia with a mortality rate of 30-70%, with most deaths occurring within 24-48 hours of symptom onset 3, 4, 5
- Streptococcus pneumoniae accounts for approximately 50% of OPSI cases 2, 3
- The risk of OPSI is highest in the first year after splenectomy but remains elevated for life, with one-third of infections occurring at least 5 years after surgery 1, 3
- Cases of fulminant infection have been reported more than 20 years after splenectomy 1, 2
Common Pitfalls to Avoid
Forgetting Lifelong Revaccination
- Do not forget lifelong revaccination schedules: MenACWY boosters every 5 years, MenB boosters every 2-3 years, and PPSV23 every 5-10 years 1, 2, 3
- Protection wanes over time, and infection risk persists for life 2
Special Populations
- Patients who received rituximab in the previous 6 months may have suboptimal vaccine response; vaccination should be reassessed once B-cell recovery has occurred 2, 3
- Children under 2 years have inherently reduced antibody response and should be reimmunized after age 2 1, 3
- Patients with functional hyposplenism (sickle cell disease, celiac disease, inflammatory bowel disease) require identical preventive measures as those with surgical splenectomy 1, 3
Inadequate Follow-Up
- Studies show that while initial vaccination rates are reasonable, booster adherence is extremely poor, with patients receiving boosters at suboptimal rates and beyond the advised timeframe 6
- Improved coordination with primary care practitioners is essential to ensure ideal defense against infectious complications 6